NAOV NANOVIBRONIX INC Disposals and divestitures 8-K Filing 2025 - Promissory Note Issued On April 11, 2025, NanoVibronix's subsidiary ENvue Medical issued a $360,000 promissory note to Alpha Capital with an 8% interest rate, and the company guaranteed the note's obligations. Additionally, on April 9, 2025, the company confirmed compliance with Nasdaq's minimum bid price and stockholder equity requirements, but will be monitored for one year.Get access to all SEC 8-K filings of the NANOVIBRONIX INC